- Home
- ASYS vs MAIA Comparison
ASYS vs MAIA Comparison
Compare ASYS & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- MAIA
- Stock Information
- Founded
- ASYS 1981
- MAIA 2018
- Country
- ASYS United States
- MAIA United States
- Employees
- ASYS N/A
- MAIA N/A
- Industry
- ASYS Industrial Machinery/Components
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- MAIA Health Care
- Exchange
- ASYS Nasdaq
- MAIA Nasdaq
- Market Cap
- ASYS 59.4M
- MAIA 46.7M
- IPO Year
- ASYS N/A
- MAIA 2022
- Fundamental
- Price
- ASYS $4.64
- MAIA $1.76
- Analyst Decision
- ASYS
- MAIA
- Analyst Count
- ASYS 0
- MAIA 0
- Target Price
- ASYS N/A
- MAIA N/A
- AVG Volume (30 Days)
- ASYS 40.9K
- MAIA 535.2K
- Earning Date
- ASYS 08-06-2025
- MAIA 08-08-2025
- Dividend Yield
- ASYS N/A
- MAIA N/A
- EPS Growth
- ASYS N/A
- MAIA N/A
- EPS
- ASYS N/A
- MAIA N/A
- Revenue
- ASYS $90,826,000.00
- MAIA N/A
- Revenue This Year
- ASYS N/A
- MAIA N/A
- Revenue Next Year
- ASYS $28.60
- MAIA N/A
- P/E Ratio
- ASYS N/A
- MAIA N/A
- Revenue Growth
- ASYS N/A
- MAIA N/A
- 52 Week Low
- ASYS $3.20
- MAIA $1.40
- 52 Week High
- ASYS $6.96
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- ASYS 58.19
- MAIA 56.41
- Support Level
- ASYS $4.66
- MAIA $1.80
- Resistance Level
- ASYS $4.94
- MAIA $2.15
- Average True Range (ATR)
- ASYS 0.25
- MAIA 0.13
- MACD
- ASYS 0.02
- MAIA 0.02
- Stochastic Oscillator
- ASYS 70.30
- MAIA 60.00
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.